Bristol Myers Squibb Receives European Commission Approval for Opdivo + Chemotherapy for Patients with HER2 Negative, Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma ... Biotech Investing
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine Pharmaceutical Investing
INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of APPH, BMY, EAR, HYZN Investors, Lead Plaintiff Deadlines Set Biotech Investing
CDC ACIP Unanimously Votes to Provisionally Recommend Merck's VAXNEUVANCE in Series with PNEUMOVAX ® 23 as an Option for Pneumococcal Vaccination in Appropriate Adults Pharmaceutical Investing
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA Medical Device Investing
Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pfizer's PREVNAR 20 in Adults Pharmaceutical Investing
Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance Medical Device Investing
The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained Biotech Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, EAR, HYZN and SAVA Biotech Investing
